Cargando…
Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome
A critical association between type II secretory phospholipase A2 (sPLA2-IIa) and established atherosclerotic cardiovascular disease has been demonstrated. However, the contribution of sPLA2-IIa to early atherosclerosis remains unknown. This study investigated the association between early-stage ath...
Autores principales: | Sun, Chang-Qing, Zhong, Chun-Yan, Sun, Wei-Wei, Xiao, Hua, Zhu, Ping, Lin, Yi-Zhang, Zhang, Chen-Liang, Gao, Hao, Song, Zhi-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5150250/ https://www.ncbi.nlm.nih.gov/pubmed/27941821 http://dx.doi.org/10.1038/srep34929 |
Ejemplares similares
-
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A(2) and secretory phospholipase A(2) in patients with newly diagnosed type 2 diabetes
por: Lin, Xiu-hong, et al.
Publicado: (2016) -
Acidification in the epidermis and the role of secretory phospholipases
por: Chan, Aegean, et al.
Publicado: (2011) -
Secretory Phospholipases A(2) in Plants
por: Mariani, María Elisa, et al.
Publicado: (2019) -
Biology of Secretory Phospholipase A(2)
por: Boyanovsky, Boris B., et al.
Publicado: (2008) -
Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)